Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA STRIDES PHARMA SCIENCE ASTRAZENECA PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 95.3 -1,463.5 - View Chart
P/BV x 22.6 3.3 686.4% View Chart
Dividend Yield % 0.3 0.2 158.2%  

Financials

 ASTRAZENECA PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
ASTRAZENECA PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3,620392 922.9%   
Low Rs2,438263 925.3%   
Sales per share (Unadj.) Rs401.2408.5 98.2%  
Earnings per share (Unadj.) Rs39.7-25.6 -155.3%  
Cash flow per share (Unadj.) Rs46.21.4 3,378.7%  
Dividends per share (Unadj.) Rs16.001.50 1,066.7%  
Avg Dividend yield %0.50.5 115.5%  
Book value per share (Unadj.) Rs234.4242.8 96.5%  
Shares outstanding (eoy) m25.0090.30 27.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.50.8 940.6%   
Avg P/E ratio x76.3-12.8 -594.8%  
P/CF ratio (eoy) x65.5239.6 27.3%  
Price / Book Value ratio x12.91.4 956.9%  
Dividend payout %40.3-5.9 -686.7%   
Avg Mkt Cap Rs m75,71829,603 255.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,5917,320 35.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,03036,884 27.2%  
Other income Rs m2611,352 19.3%   
Total revenues Rs m10,29138,236 26.9%   
Gross profit Rs m1,249830 150.5%  
Depreciation Rs m1632,433 6.7%   
Interest Rs m62,611 0.2%   
Profit before tax Rs m1,341-2,862 -46.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m348-553 -62.9%   
Profit after tax Rs m993-2,309 -43.0%  
Gross profit margin %12.52.2 553.5%  
Effective tax rate %26.019.3 134.3%   
Net profit margin %9.9-6.3 -158.1%  
BALANCE SHEET DATA
Current assets Rs m9,35931,353 29.9%   
Current liabilities Rs m4,84429,902 16.2%   
Net working cap to sales %45.03.9 1,144.8%  
Current ratio x1.91.0 184.3%  
Inventory Days Days4971 69.5%  
Debtors Days Days39129 30.4%  
Net fixed assets Rs m2,06131,300 6.6%   
Share capital Rs m50903 5.5%   
"Free" reserves Rs m5,81121,025 27.6%   
Net worth Rs m5,86121,928 26.7%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m11,42163,734 17.9%  
Interest coverage x213.9-0.1 -222,871.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.6 151.7%   
Return on assets %8.70.5 1,843.7%  
Return on equity %16.9-10.5 -160.9%  
Return on capital %23.0-0.8 -3,057.2%  
Exports to sales %046.7 0.0%   
Imports to sales %37.40-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs m3,747NA-   
Fx inflow Rs m61218,113 3.4%   
Fx outflow Rs m3,747672 558.0%   
Net fx Rs m-3,13517,442 -18.0%   
CASH FLOW
From Operations Rs m583444 131.3%  
From Investments Rs m1813,025 6.0%  
From Financial Activity Rs m-245-2,139 11.4%  
Net Cashflow Rs m5191,328 39.1%  

Share Holding

Indian Promoters % 0.0 27.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 38.9 13.9%  
FIIs % 2.7 19.5 13.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 72.6 34.4%  
Shareholders   29,032 91,182 31.8%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs STRIDES PHARMA SCIENCE Share Price Performance

Period ASTRAZENECA PHARMA STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day -0.22% 1.73% 1.45%
1-Month -3.84% 0.91% -0.48%
1-Year 58.83% 178.44% 62.26%
3-Year CAGR 20.41% -3.17% 18.27%
5-Year CAGR 22.13% 11.10% 19.85%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.